Teleflex says peer-reviewed study shows 70% lower CLABSI hazard with Arrowg+ard technology

Teleflex said a peer-reviewed study in the American Journal of Infection Control found CVCs protected with Arrowg+ard technology were associated with a 70% lower hazard of CLABSI over 30 days. The study covered 1,750 critically ill patients across six hospitals in four countries.